Literature DB >> 9368777

Chronic remodeling pathology in grafts.

C G Orosz1, R P Pelletier.   

Abstract

The theoretical basis of chronic allograft rejection remains poorly defined, but is clearly associated with the development of a relatively unique vasculopathy, transplant vascular sclerosis (TVS). The hypothesis that TVS is the cause of chronic rejection has yet to be proven, although it is widely accepted. Accumulating data suggest that, at best, the hypothesis is incomplete. The challenge for transplant investigators is to review the currently available data and to develop a testable, revised version of the hypothesis that explains both the antigen-dependent and antigen-independent contributions to graft vascular remodeling, and that encompasses all reasonable alternative mechanisms of graft failure.

Entities:  

Mesh:

Year:  1997        PMID: 9368777     DOI: 10.1016/s0952-7915(97)80048-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  8 in total

1.  Abdominal aorta transplantation after programmed cryopreservation.

Authors:  Song Gu; Chang-Jian Liu; Tong Qiao; Xue-Mei Sun; Jun-Hao Chen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

2.  Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.

Authors:  A Le Moine; V Flamand; F X Demoor; J C Noël; M Surquin; R Kiss; M A Nahori; M Pretolani; M Goldman; D Abramowicz
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.

Authors:  Eliot G Peyster; Andrew Janowczyk; Abigail Swamidoss; Samhith Kethireddy; Michael D Feldman; Kenneth B Margulies
Journal:  Circulation       Date:  2022-04-11       Impact factor: 39.918

4.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

5.  Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection.

Authors:  J A Diaz; A J Booth; G Lu; S C Wood; D J Pinsky; D K Bishop
Journal:  Am J Transplant       Date:  2009-06-16       Impact factor: 8.086

6.  Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Bernard L Marini; Weiping Zou; David Gordon; Yoichiro Iwakura; Yasmina Laouar; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

7.  TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Sherri C Wood; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

8.  Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis.

Authors:  Pragyi Shrestha; Kirankumar Katta; Ditmer Talsma; Annamaria Naggi; Jan-Luuk Hillebrands; Bart van de Sluis; Jacob van den Born
Journal:  Front Cell Dev Biol       Date:  2022-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.